The effect of garlic on fatigue and quality of life in MS patients
Phase 3
- Conditions
- Multiple Sclerosis.Multiple sclerosis
- Registration Number
- IRCT20150721023282N15
- Lead Sponsor
- Esfahan University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 56
Inclusion Criteria
Relapsing-remitting MS
At least 6 months have passed since the diagnosis
Complaints of obvious fatigue
Exclusion Criteria
Pregnancy
Breastfeeding
Diseases causing fatigue
acute recurrence stage
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Fatigue severity. Timepoint: Before and after the intervention. Method of measurement: fatigue severity sacle (fss).;Quality of life. Timepoint: Before and after the intervention. Method of measurement: The Short Form Health Survey (SF-36).
- Secondary Outcome Measures
Name Time Method
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What molecular mechanisms of Allium sativum extract improve fatigue in multiple sclerosis patients in phase III trials?
How does garlic extract (Allium sativum) compare to standard MS fatigue treatments like amantadine or modafinil in efficacy and safety?
Which biomarkers predict response to garlic extract (Allium sativum) in IRCT20150721023282N15 MS fatigue trials?
What are the safety profiles and adverse event management strategies for Allium sativum extract in phase III MS clinical trials?
Are there synergistic effects when combining garlic extract (Allium sativum) with standard MS therapies like interferon beta or glatiramer acetate?